Welcome to our dedicated page for inTEST Corporation news (Ticker: $INTT), a resource for investors and traders seeking the latest updates and insights on inTEST Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect inTEST Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of inTEST Corporation's position in the market.
inTEST (NYSE American: INTT) reported $29.8 million in revenue for the first quarter of 2024, representing a 7% increase sequentially. The revenue growth was driven by the Alfamation acquisition, which contributed $1.4 million. Despite a decline in overall sales compared to the prior year, the company adjusted its full-year revenue expectation to $140-150 million, reflecting an 18% growth over 2023. Earnings per diluted share were $0.05, while adjusted earnings per diluted share stood at $0.10. The company generated $2.1 million in cash from operations during the quarter, with cash at March 31, 2024, totaling $27.3 million.
inTEST (NYSE American: INTT) announced a four-year extension of its non-revolving delayed draw term loan and revolving credit facility, and a two-year extension of the draw-down window for the term loan. The maturity date of the term loan and revolving credit facility was extended to May 2, 2031, with a draw-down period until May 2, 2026. The Company has approximately $30 million available funding on the $50.5 million term loan and the full $10 million available under the revolving credit facility. Interest rates are based on the Secured Overnight Financing Rate (SOFR) or a bank-defined base rate plus an applicable margin of at least 2.1%, with an annual interest rate of approximately 7.4% based on current SOFR and leverage. The credit facility and term loan are secured by substantially all of the Company's assets.
inTEST (INTT) has launched the Temptronic RapidTemp™ BT28 ThermoStream®, a cutting-edge benchtop temperature test system for electronics and semiconductor thermal testing. The system offers precise temperature control, high accuracy, rapid transitions, and a compact design. It is aimed at industries such as semiconductor and electronics, providing top-tier performance in a small package. The BT28 is designed to enhance user experience, maximize workspace efficiency, and accelerate product development timelines.